Teneligliptin and “Thorough QTc study”: thorough enough?
Samit GhosalDepartment of Endocrinology, Nightingale Hospital, Kolkata, IndiaI read with interest the “Thorough QTc study” with teneligliptin by Erande et al.1 It came as a surprise to me that the basic structure required to conduct such a trial as per the ICH E...
Main Author: | Ghosal S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/teneligliptin-and-ldquothorough-qtc-studyrdquo-thorough-enough-peer-reviewed-article-DMSO |
Similar Items
-
QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)
by: Erande S, et al.
Published: (2019-06-01) -
Thorough;
by: White, David Allen, M. Arch Massachusetts Institute of Technology.
Published: (2021) -
No QTc Prolongation With Zanubrutinib: Results of Concentration‐QTc Analysis From a Thorough QT Study in Healthy Subjects
by: Song Mu, et al.
Published: (2020-09-01) -
Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study
by: Shen Z, et al.
Published: (2016-10-01) -
A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjects
by: Sibel Ucpinar, et al.
Published: (2022-06-01)